Malaysian Life Sciences Capital Fund
VC Fund
Kuala Lumpur, Malaysia
Malaysian Life Sciences Capital Fund is a Malaysian venture capital firm specialized in early-stage investments in biotechnology.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 31%
- Fund size:
- $162M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Malaysian Life Sciences Capital Fund invests in
BiotechnologyRenewable EnergyCleanTechHealth CareFuel
Stages Malaysian Life Sciences Capital Fund invests in
Series CSeries BSeries DFunding RoundGrant
Countries Malaysian Life Sciences Capital Fund invests in
United StatesMalaysia
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Chen Yee Liaw
|
|||
Ganesh Kishore
|
|||
|
Ginny Leong
|
|||
Greg B. Young
|
|||
|
Nelleita Omar
|
Investment Focus
Industry
- Biotechnology 5 (31%)
- Renewable Energy 4 (25%)
- CleanTech 3 (19%)
- Health Care 3 (19%)
- Fuel 2 (13%)
Stage
- Series C 5 (31%)
- Series B 4 (25%)
- Series D 4 (25%)
- Funding Round 2 (13%)
- Grant 1 (6%)
Country
- United States 10 (63%)
- Malaysia 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chen Yee Liaw
Analyst
|
Analyst | Total investments: 0 | Find email | |
|
Ganesh Kishore
CEO
|
CEO | Total investments: 9 | Find email | |
|
Ginny Leong
Office Manager
|
Office Manager | Total investments: 0 | Find email | |
|
Greg B. Young
Investment Manager
|
Investment Manager | Total investments: 6 | Find email | |
|
Nelleita Omar
Director of Special Projects
|
Director of Special Projects | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Crop Enhancement
|
Crop Enhancement develop a new approach that will help farmers increase crop yields and profitability in a sustainable way. By developing agrochemical formulations that employ advanced and environmentally friendly chemistry, we help improve crop yields, eliminate or minimize pesticide use, and enable precise and effective delivery of activeingredients and fertilizers. | $8.5M / Series B / Sep 13, 2016 | |
LanzaTech
|
LanzaTech is turning our global carbon crisis into a feedstock opportunity with the potential to displace 30% of crude oil use today and reduce global CO2 emissions by 10%. By recycling carbon from industrial off-gases; syngas generated from any biomass resource (e.g. municipal solid waste (MSW), organic industrial waste, agricultural waste); andreformed biogas, LanzaTech can reduce emissions and make new products for a circular carbon economy.LanzaTech’s carbon recycling technology is like retrofitting a brewery onto an emission source like a steel mill or a landfill site, but instead of using sugars and yeast to make beer, pollution is converted by bacteria to fuels and chemicals! Imagine a day when your plane is powered by recycled GHG emissions, when your yoga pants started life as pollution from a steel mill. This future is possible using LanzaTech technology. | $112M / Series D / Dec 08, 2014 | |
|
LanzaTech
|
LanzaTech is turning our global carbon crisis into a feedstock opportunity with the potential to displace 30% of crude oil use today and reduce global CO2 emissions by 10%. By recycling carbon from industrial off-gases; syngas generated from any biomass resource (e.g. municipal solid waste (MSW), organic industrial waste, agricultural waste); andreformed biogas, LanzaTech can reduce emissions and make new products for a circular carbon economy.LanzaTech’s carbon recycling technology is like retrofitting a brewery onto an emission source like a steel mill or a landfill site, but instead of using sugars and yeast to make beer, pollution is converted by bacteria to fuels and chemicals! Imagine a day when your plane is powered by recycled GHG emissions, when your yoga pants started life as pollution from a steel mill. This future is possible using LanzaTech technology. | $55.8M / Series C / Nov 24, 2013 | |
FLEXIROAM
|
Flexiroam works with an overseas SIM to allow you to make & receive unlimited international roaming calls. It is the cheapest way to roam without worry when you travel overseas. | $152K / Grant / Jul 25, 2013 | |
Akermin
|
Akermin is based in St. Louis, Missouri, and was formed in 2004 to commercialize breakthrough stabilized enzyme technology invented at Saint Louis University. In 2008, Akermin demonstrated its prototype of a fully functioning biofuel cell operating on methanol fuel and using stabilized laccase to replace the metal catalyst in conventionalcathodes. Commercial applications in wireless sensors and military uses are their primary focus. Development for the use of stabilized enzymes in the food processing, biofuels, chemical, and pharmaceutical industries is under way. | $1.5M / Feb 19, 2013 | |
Segetis
|
Segetis, Inc., a green chemistry company, engages in the development, production, and commercialization of renewable polymers. The company focuses on a platform of binary monomers based on renewable feed stocks. The company's technology enables the use of non-food agricultural and forestry feed stocks for the production of various materials,as well as enables the second wave of industrial bioproducts, such as bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other compounds for specialty chemical applications. Its chemistries offer various opportunities for product enablement and synergies for industries engaged in the processing of starch and sugar crops; processing of wood, cellulose, and paper pulp; chemical processing of vegetable oils; manufacturing of biodiesel; and the manufacturing of linear alpha-olefins and other compounds. The company was founded in 2006 and is based in Golden Valley, Minnesota. | $25.5M / Series C / Aug 15, 2012 | |
Glori Energy
|
Glori Energy's mission is to cleanly and safely recover billions of barrels of oil that are trapped in existing well reservoirs without having to drill a single new well. Glori partners with oil producers to install the AEROTM (Activated Environment for Recovery of Oil) System to significantly increase oil production. The AEROâ„¢ Systemprovides a new, viable low-cost option to cleanly and safely recover previously trapped oil and bring it to market. | $20M / Series C / Jan 24, 2012 | |
Chromatin
|
Chromatin is a biotech company developing and marketing innovative technologies and products that benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors. Chromatin is unlocking the potential of plants to produce greater value and meaningful products for consumers, growers, seed producers, and bioprocessors. Chromatin iscommercializing solutions that proactively address key societal challenges such as improving agricultural productivity and increasing renewable energy resources. | $10M / Series D / Oct 25, 2011 | |
Cobalt Technologies
|
Cobalt Technologies develops technologies that focuses and designed for biofuels. Cobalt is pioneering science that makes possible a new generation of fuels that burn cleaner, are more cost-effective and have a smaller environmental impact. It was founded in 2005 and headquartered in Mountain View, California. | Series D / May 02, 2011 | |
|
Akermin
|
Akermin is based in St. Louis, Missouri, and was formed in 2004 to commercialize breakthrough stabilized enzyme technology invented at Saint Louis University. In 2008, Akermin demonstrated its prototype of a fully functioning biofuel cell operating on methanol fuel and using stabilized laccase to replace the metal catalyst in conventionalcathodes. Commercial applications in wireless sensors and military uses are their primary focus. Development for the use of stabilized enzymes in the food processing, biofuels, chemical, and pharmaceutical industries is under way. | $10M / Series B / Jan 26, 2010 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Energy Investors
25,111 investors
Biotech Investors
21,775 investors
Impact Investors
20,240 investors
Sustainability Investors
20,240 investors
Biotechnology Investors
19,370 investors
Renewable Energy Investors
8,337 investors
CleanTech Investors
4,916 investors
FAQ
What does Malaysian Life Sciences Capital Fund invest in?
Malaysian Life Sciences Capital Fund invests primarily in Biotechnology, Renewable Energy and CleanTech startups, most often at Series C and Series B stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Malaysian Life Sciences Capital Fund?
Public channels for Malaysian Life Sciences Capital Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Malaysian Life Sciences Capital Fund?
The team at Malaysian Life Sciences Capital Fund includes Chen Yee Liaw (Analyst), Ganesh Kishore (CEO) and Ginny Leong (Office Manager), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
